EP0005914A1 - Procédé chimique pour la préparation d'inhibiteurs de bêta-lactamase et les composés ainsi obtenus - Google Patents

Procédé chimique pour la préparation d'inhibiteurs de bêta-lactamase et les composés ainsi obtenus Download PDF

Info

Publication number
EP0005914A1
EP0005914A1 EP79300779A EP79300779A EP0005914A1 EP 0005914 A1 EP0005914 A1 EP 0005914A1 EP 79300779 A EP79300779 A EP 79300779A EP 79300779 A EP79300779 A EP 79300779A EP 0005914 A1 EP0005914 A1 EP 0005914A1
Authority
EP
European Patent Office
Prior art keywords
formula
compound
group
process according
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP79300779A
Other languages
German (de)
English (en)
Inventor
Gerald Brooks
John Sydney Davies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of EP0005914A1 publication Critical patent/EP0005914A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Definitions

  • British Patent Application 03892/76-19002/76 discloses thioether derivatives of clavulanic acid, pharmaceutical compositions containing them and a process for their preparation.
  • the disclosed process comprised the reaction of an ester of clavulanic acid with a thiol and thereafter if desired converting the thus formed ester of the thioether into the corresponding free acid or its salt.
  • the process disclosed is very versatile leading to the preparation of a wide class of thioethers it suffers from the disadvantage of giving only relatively poor yields.
  • the later French Published Patent Application No. 2,342,292 also discloses the preparation of thioethers of clavulanic acid by the reaction of a sulphur nucleophile with an ester of 9-halo or 9-acyloxydeoxyclavulanic acid.
  • a synthesis has now been found that has the advantage that it may be carried out at ambient temperature if desired, does not involve the use of foul smelling thiols at the coupling stage but instead employs easily weighable, solid sulfenimide intermediates.
  • the intermediates used in this process are also conveniently accessible and used, for example by the methods of M.Behforouz and J.E. Kenwood, J. Org. Chem., 34, 51 (1969) or K.A.M. Walker, Tet. Lett., 4475 (1977).
  • the use of this process for preparing aryl thioethers offers the further advantage of particularly good yields.
  • the present invention provides a process for the preparation of thioether derivatives of deoxyclavulanic acid of the formula (I): wherein R 1 is the residue of a thiolR 1 SH and R 2 is a group such that C0 2 R 2 represents a carboxylic acid moiety or a salt or ester thereof; which process comprises the reaction of a compound of the formula (II): with a compound of the formula (III): and a compound of the formula (IV): in which compounds R 1 is as defined in relation to formula (I); R 3 and R 4 are moieties such that the compound of the formula (II) is a sulfenimide; R 5 is a group such that the compound of the formula (III) is an ester of clavulanic acid; and R 6 , R 7 and R 8 are groups such that the compound of the formula (IV) is a phosphine; and thereafter if desired converting the thus formed compound of the formula (I) wherein R 2 is a group such that C0
  • Suitable groups R include hydrocarbon groups and hydrocarbon groups substituted by a group of the sub-formulae OR 9 , O.CO.R 9 , C O.R 9 , C0 2 R 9 , NH.C O .R 9 , NR 10 .COR 9 and NR 10 CO 2 R 9 wherein R 9 is a. lower alkyl group or lower aralkyl group and R 10 is a lower alkyl group.
  • hydrocarbon includes alkyl, alkenyl, phenyl and phenylalkyl groups.
  • lower means that the group contains up to 4 carbon atoms.
  • aralkyl means a lower alkyl group substituted by a phenyl group.
  • R include the methyl, ethyl, n-propyl, n-butyl, phenyl, benzyl, allyl, 2-methoxyethyl, 4-methoxyphenyl, 4-methoxybenzyl and the like.
  • Preferred groups R 1 include optionally substituted phenyl groups.
  • R are optionally substituted aromatic heterocyclic groups, such as pyridyl, furyl, thienyl and the like.
  • R 1 is an optionally substituted aromatic group.
  • Suitable groups -CO 2 R 2 include those of the sub-formulae -CO 2 A 1 or -C0 2 CHA 2 A 3 wherein A is a lower alkyl group optionally substituted by a group OA 4 , O.CO.A 4 or O.CO.O.A 4 wherein A 4 is a lower alkyl or phenyl group; A 2 is a lower alkenyl, lower alkynyl, phenyl group or phenyl group substituted by a halogen atom or nitro, A 5 , OA 5 or O.CO.A 5 group where A 5 is a lower alkyl group; and A3 is a hydrogen atom or a phenyl group or a phenyl group substituted by a halogen atom or a nitro, A 5 , O A 5 or O.CO.A 5 group where A 5 is a lower alkyl group; or -CHA 2 A 3 represents a phthalidyl group.
  • the -C0 2 R 2 group is one readily cleaved by mild base, for example a lower alkyl or lower alkoxymethyl group.
  • the -C0 2 R 2 group is one readily cleaved by hydrogenolysis, for example a benzyl group optionally substituted by a halogen atom or a nitro, A 5 , OA 5 or O.CO.A 5 group where A 5 is a lower alkyl group.
  • a benzyl group optionally substituted by a halogen atom or a nitro, A 5 , OA 5 or O.CO.A 5 group where A 5 is a lower alkyl group.
  • the benzyl, p-methoxybenzyl and p-nitrobenzyl group are particularly favoured.
  • the groups R 3 and R 4 will normally be selected from hydrocarbon groups which may be linked together. Particularly apt groups R 3 and R 4 include lower alkyl groups optionally linked to form part of a 5- or 6- membered ring.
  • Preferred compounds of the formula (II) include those of the formulae (V) and (VI): wherein R 1 is as defined in relation to formula (I).
  • the compounds of the formula (V) are particularly suitable as a by-product of the reaction is water-soluble and may thus be readily removed by washing with water.
  • Suitable values for R 6 , R 7 and R 8 include hydrocarbon groups of up to 7 carbon atoms and hydrocarbon groups substituted by a group of the sub-formulae OR 11 or O.CO.R 11 where R 11 is a lower alkyl group.
  • R 6 , R 7 and R 8 each have the same meaning.
  • R 6 , R 7 and R 8 include methyl, ethyl, n-propyl, n-butyl, phenyl, 4-methoxyphenyl and benzyl.
  • a particularly suitable compound of the formula (IV) is tri-n-butyl-phosphine.
  • the reaction of the compounds of the formulae (II), (III) and (IV), may take place at any convenient non- extreme temperature, for example -10°C to 50 o C, more usually 0° to 40°C, generally 10° to 30°C and very conveniently at ambient (about 15-25°C).
  • the reaction is generally carried out in an aprotic medium.
  • Suitable solvents include hydrocarbon solvents such as benzene, toluene and the like.
  • reaction may be carried out under an inert gas such as nitrogen.
  • the mixture may be washed with water to remove the water-soluble products, and the organic layer dried and evaporated.
  • the initial product may be further purified by chromatography if desired, for example over silica eluting with ethyl acetate/petroleum ether or the like.
  • ester of the thioether may be converted to the corresponding acid or salt in conventional manner, for example as described in Belgian Patent No. 847045.
  • N-(pyrid-4-ylthio) succinimide (0.100g,0.48 mmole) was added to a solution of tri-n-butylphosphine (0.118ml, 0.48 mmole) in THF (5ml) under nitrogen and stirred 5 minutes.
  • p-Nitrobenzyl clavulanate (0.100g,0.30 mmole) was added and stirring continued for 30 minutes.
  • the solution was diluted with ethyl acetate (30 ml), washed with water (2 x 20 ml), dried over MgS0 4 and evaporated.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EP79300779A 1978-05-30 1979-05-08 Procédé chimique pour la préparation d'inhibiteurs de bêta-lactamase et les composés ainsi obtenus Withdrawn EP0005914A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2404678 1978-05-30
GB2404678 1978-05-30

Publications (1)

Publication Number Publication Date
EP0005914A1 true EP0005914A1 (fr) 1979-12-12

Family

ID=10205526

Family Applications (1)

Application Number Title Priority Date Filing Date
EP79300779A Withdrawn EP0005914A1 (fr) 1978-05-30 1979-05-08 Procédé chimique pour la préparation d'inhibiteurs de bêta-lactamase et les composés ainsi obtenus

Country Status (4)

Country Link
EP (1) EP0005914A1 (fr)
JP (1) JPS54157597A (fr)
CA (1) CA1126733A (fr)
ES (1) ES481098A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2342292A1 (fr) * 1976-02-27 1977-09-23 Glaxo Lab Ltd Antibiotiques, inhibiteurs de b-lactamases, clavulamiques et leur procede de preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2342292A1 (fr) * 1976-02-27 1977-09-23 Glaxo Lab Ltd Antibiotiques, inhibiteurs de b-lactamases, clavulamiques et leur procede de preparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SYNTHESIS, INTERNATIONAL JOURNAL OF METHODS IN SYNTHETIC ORGANIC CHEMISTRY, No. 4, April 1974 Georg Thieme Verlag Stuttgart (DE) M. FURUKAWA: "Preparation of Unsymmetrical Sulfides" pages 282-283 * complete article * *
TETRAHEDRON LETTERS, No. 51, December 1977 Pergamon Press Oxford (GB) K.A.M. WALKER: "A convenient preparation of thioethers from alcohols" pages 4475-4478 * complete document * *

Also Published As

Publication number Publication date
JPS54157597A (en) 1979-12-12
CA1126733A (fr) 1982-06-29
ES481098A1 (es) 1980-03-01

Similar Documents

Publication Publication Date Title
FR2676447A1 (fr) Nouveaux derives du thiopyranopyrrole et leur preparation.
EP0023097B1 (fr) Dé-arylméthylation de N-mono- ou N-diarylméthyl-bêta-lactames; azétidinones à activité anti-bactérienne
EP0037592A2 (fr) Composés contenant le groupement bêta-lactame
FR2472574A1 (fr) Derives de cephalosporine et composition pharmaceutique les contenant
EP0008514B1 (fr) Dérivés antibactériens de bêta-lactames, compositions les contenant et un procédé pour leur préparation
US5599946A (en) 3-(2-trialkylsilyloxy)ethyl-7-ethyl-1H-indoles and method for their preparation
US4071529A (en) Derivatives of 6-aminopenicillanic acid
EP0005914A1 (fr) Procédé chimique pour la préparation d'inhibiteurs de bêta-lactamase et les composés ainsi obtenus
JP2648472B2 (ja) β−ラクタム化合物及びその製造方法
FR2496666A1 (fr) Nouveaux derives de cephalosporine et composition pharmaceutique les contenant
EP0051234B1 (fr) Procédé de préparation de dérivés de la 2-azétidinone
EP0104010B1 (fr) Intermédiaires pour dérivés d'acide clavulanique
US4683300A (en) Deadcat reaction for making 9-deoxy-9-isocyanato clavulanates
EP0033209B1 (fr) Composés dérivés de bêta-lactame, leur préparation et leur utilisation
FI71562C (fi) Foerfarande foer framstaellning av 6- - substituerade penicillansyraderivat och saosom mellanprodukter anvaendbara 6-perfluoralkylsulfonyloxipenicillansyraderivat.
EP0066373B1 (fr) Dérivés de bêta-lactame, procédé de préparation et les compositions les contenant
EP0009302B1 (fr) Dérivés de l'acide clavulanique et procédé pour leur préparation
KR830002380B1 (ko) 카바페넴계 항생물질 유도체의 제조방법
US3926956A (en) Process for the preparation of ampicillin
CA1107739A (fr) COMPOSES DE TYPE .beta.-LACTAME
US4296032A (en) Method for the preparation of penicillanic-β-lactamase inhibitors
SU791244A3 (ru) Способ получени оксазолиноазетидиновых соединений
US4099000A (en) Process for preparing di-7-azido cephalosporin compounds
CA1152999A (fr) Procede de preparation de derives de l'acide clavulanique
HU176007B (en) Process for producing 7-alpha-alkoxy-ceph-3-eme-derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): BE CH DE FR GB IT NL SE

17P Request for examination filed
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BEECHAM GROUP PLC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19830328

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BROOKS, GERALD

Inventor name: DAVIES, JOHN SYDNEY